• 1. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Phthalic acid and derivatives

Comprehensive Overview of 3-(Methoxycarbonyl)-4-methylbenzoic acid (CAS 167300-06-3): Properties, Applications, and Industry Relevance

3-(Methoxycarbonyl)-4-methylbenzoic acid (CAS 167300-06-3) is a specialized organic compound widely recognized for its versatile applications in pharmaceutical intermediates, agrochemical synthesis, and material science. This methylbenzoic acid derivative features a methoxycarbonyl group at the 3-position and a methyl substituent at the 4-position, contributing to its unique reactivity and solubility profile. As demand for high-precision chemical building blocks grows, this compound has garnered attention for its role in peptide coupling reactions and heterocyclic compound synthesis.

Recent trends in green chemistry have spotlighted 167300-06-3 as a candidate for eco-friendly catalytic processes. Researchers are exploring its potential in biodegradable polymer formulations, aligning with global sustainability initiatives. The compound's balanced lipophilicity (LogP ~2.1) and moderate acidity (pKa ~4.3) make it particularly valuable for designing pH-sensitive drug delivery systems – a hot topic in nanomedicine research.

From a synthetic perspective, 3-(Methoxycarbonyl)-4-methylbenzoic acid serves as a key precursor for nonsteroidal anti-inflammatory drug (NSAID) analogs. Its benzoic acid core allows straightforward derivatization into esters and amides, while the electron-withdrawing methoxycarbonyl group enhances reactivity in nucleophilic aromatic substitutions. These properties answer frequent search queries about "carboxylic acid activators" and "aromatic substitution patterns" in organic chemistry forums.

Analytical characterization of CAS 167300-06-3 typically involves HPLC purity analysis (≥98%), FTIR spectroscopy (characteristic C=O stretch at 1720 cm?1), and proton NMR (δ 2.4 ppm for methyl protons). These standardized protocols address common quality control questions from industrial buyers. The compound's stability under ambient storage conditions (recommended 2-8°C in amber glass) makes it practical for small-scale research and bulk manufacturing alike.

Emerging applications in OLED materials have further elevated interest in this compound. Its conjugated aromatic system demonstrates promising electroluminescent properties when incorporated into organic semiconductors – a response to growing searches about "advanced material precursors". Manufacturers now offer customized particle size distributions and solubility-enhanced formulations to meet diverse research needs.

Regulatory compliance remains straightforward for 167300-06-3, as it falls outside restricted substance lists in most jurisdictions. Safety data sheets emphasize standard laboratory precautions (gloves, goggles) rather than specialized handling – an important distinction for researchers comparing benzoic acid derivatives. This regulatory profile supports its growing adoption in international research collaborations.

The compound's structure-activity relationships continue to inspire medicinal chemistry studies. Computational modeling suggests the methoxycarbonyl group enhances target binding affinity in certain enzyme inhibitors, explaining its prevalence in fragment-based drug discovery libraries. These findings directly address trending queries about "scaffold hopping strategies" in drug development.

Looking ahead, 3-(Methoxycarbonyl)-4-methylbenzoic acid is poised to play a pivotal role in high-throughput screening platforms and combinatorial chemistry workflows. Its compatibility with automated synthesis systems and flow chemistry reactors positions it as a future-proof building block for next-generation chemical innovation.

• 170433-63-3(1,2-Benzenedicarboxylic acid, 4-(hydroxymethyl)-, dimethyl ester)
• 85448-30-2(Dimethyl phthalate-d)
• 21483-46-5(3-Methyl-phthalic Acid dimethyl ester)
• 116934-87-3(4-(Methoxycarbonyl)-3-methylbenzoic Acid)
• 14346-57-7(1,2-Benzenedicarboxylic acid, 3-methyl-, 1-methyl ester)
• 7498-53-5(4-(methoxycarbonyl)-2,6-dimethylbenzoic acid)
• 20116-65-8( )
• 64441-70-9(dimethyl benzene-1,2-dicarboxylate)
• 1217-12-5(1,2-Benzenedicarboxylic acid, 3,4,5,6-tetramethyl-, dimethyl ester)
• 17649-59-1(1,2-Benzenedicarboxylic acid, 4,5-dimethyl-, dimethyl ester)